The system is designed to clean and debride chronic and contaminated wounds more effectively than manual methods.

Current treatment methods for diabetic wounds include surgical debridement, negative pressure wound therapy, vascularized flaps, and different types of local dressings. Among these dressings, commonly ...

If the tissue can be loosened beyond the area that has been debrided, further debridement may be necessary ... 1999). Since wound closure in these patients may be primary, secondary, or delayed ...

Secured additional R&D collaborations with Solventum and Mölnlycke for optimal trial consistency and patient outcomesStudy to support ...

One of the most serious complications of diabetes is loss of circulation, and ultimately, loss of sensation to the feet. These issues put patients with diabetes at greater risk for foot ulcers, ...

Building on its proprietary enzymatic platform, MediWound is advancing EscharEx®, a promising candidate currently in Phase III development for the debridement of chronic wounds. With distinct ...

Lonzo Ball is officially back. After two-and-a-half seasons missed due to a litany of knee issues, the Chicago Bulls guard ...

Kane will be introducing XSONX to Canadian practitioners starting today at the Wounds Canada National Hybrid Conference in conjunction with its revyve™ antimicrobial wound gel and revyve™ ...

Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...

Smith & Nephew PLC (UK), Cardinal Health (US), Medtronic PLC (Ireland), B. Braun Melsungen AG (Germany), Baxter International ...

We are confident that EscharEx will demonstrate superior efficacy, addressing critical unmet needs in enzymatic debridement for patients with chronic wounds." The randomized, prospective study ...